Sign in
CompletedNo phase

Utilization of Aspirin for Prevention of Pre-Eclampsia in Nigeria: A Explanatory Sequential Mixed Methods Study

Key facts

Who runs it
Washington University School of Medicine
Where
Nigeria4 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
1,200 people enrolled
Started
31 Oct 2023
Ended
30 Nov 2024
Type of study
Observational, 4 groups
Treatments tested
  • Exposure of interest - Moderate or High-risk Preeclampsia
Record updated
2 July 2025

Who can take part

Age
18 years to 40 years
Sex
Women only
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Adult pregnant woman > 18 years old / emancipated pregnant minors (<18years), according to the stipulations of the Nigerian National Health Research Ethics Committee (NRHEC)
  • >12 weeks' gestation attending antenatal care clinics on 2nd or subsequent visit
  • Those presenting to the labor and delivery room

Who cannot take part

  • Unable to provide consent

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this study is to evaluate the use of aspirin for the prevention of preeclampsia among moderate -to- high-risk pregnant women in tertiary care hospitals in Nigeria followed by a qualitative study to evaluate the barriers and facilitators of aspirin use in prenatal care for the prevention of preeclampsia in Nigeria. The main question[s] it aims to answer are:

Read full original descriptionShow less

1. Is Aspirin used for the prevention of preeclampsia among pregnant women in Nigeria? 2. What factors promote or prevent the utilization of Aspirin for preeclampsia prevention among pregnant women in Nigeria.

The 4 groups in the trial

  • University of Abuja Teaching Hospital

    Pregnant women with Hypertensive Disorder of Pregnancy who seek care in the Federal Capital Territory, attending antenatal clinics on the 2nd or subsequent visit and pregnant women presenting to the labor and delivery room.

    Treatment: Exposure of interest - Moderate or High-risk Preeclampsia

  • Amino Kano Teaching Hospital

    Pregnant women with Hypertensive Disorder of Pregnancy who seek care in Kano State in Nigeria, attending antenatal clinics on the 2nd or subsequent visit and pregnant women presenting to the labor and delivery room.

    Treatment: Exposure of interest - Moderate or High-risk Preeclampsia

  • National Hospital, Abuja

    Pregnant women with Hypertensive Disorder of Pregnancy who seek care in the Federal Capital Territory, attending antenatal clinics on the 2nd or subsequent visit and pregnant women presenting to the labor and delivery room.

    Treatment: Exposure of interest - Moderate or High-risk Preeclampsia

  • Murtala Muhammad Specialist Hospital

    Pregnant women with Hypertensive Disorder of Pregnancy who seek care in Kano State in Nigeria, attending antenatal clinics on the 2nd or subsequent visit and pregnant women presenting to the labor and delivery room.

    Treatment: Exposure of interest - Moderate or High-risk Preeclampsia

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
2 July 2025